Alvotech Group Transfers 2.7M Shares at $4.74 per Share
ATP Holdings ehf sold 2,701,617 Alvotech shares on January 30, 2026 to Aztiq Pharma Partners at USD 4.74 per share in an intra-group transfer. The filings with Luxembourg’s CSSF highlight this transfer and suggest a current equity valuation reference for Alvotech.
1. Transaction Details
On January 30, 2026, ATP Holdings ehf., part of the Aztiq group, sold 2,701,617 Alvotech shares to fellow group entity Aztiq Pharma Partners at USD 4.74 per share, constituting a transfer of ownership within the group.
2. Regulatory Reporting
Both sides of the transaction were disclosed in filings submitted to the Luxembourg Commission de Surveillance du Secteur Financier (CSSF), fulfilling insider transaction reporting requirements for managers and closely associated persons.
3. Valuation Implications
The USD 4.74 price per share provides a recent transaction-based reference point for Alvotech’s equity value, although the intra-group nature means there was no net change in overall group ownership.